SEP 04, 2018 3:00 PM PDT

Metal beads that could help reduce chemotherapy side effects in brain tumor

WRITTEN BY: Heba El Wassef

Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects because of their treatment.

Surgery is the most widely used treatment to remove the tumor in the brain. In benign tumors, surgery alone can cure the disease. But in malignant “cancer” and inoperable tumor cases, patients will need to have radiation or chemotherapy.

The problem with chemotherapy that it does not only kill the cancer cells but also affects the healthy cells around the tumor which causes a lot of unwanted side effects to patients which limits how much of the drug can be used and affect its effectiveness.

Therefore researchers are always trying to find new ways of treatment that could help eliminate the tumor with minimal side effects.

Researchers at the Cancer Research UK Edinburgh Centre are trying to solve this, by inventing a new way of delivering the chemotherapy drug only to the tumor cells without affecting any healthy cells.

They use the famous chemotherapy drug temozolomide and modify it in such a way that it can travel through the body without causing any harm to the healthy cells as it remains inactive.

It only gets activated when it interacts with tiny metal beads from palladium metal that are inserted in the tumor area; then it can kill any tumor cells left.

This new therapy could hopefully treat more patients and eliminates the unwanted side effects.

Radiation beads and chemotherapy beads have also been used to treat cancer patients.

 

 

About the Author
  • A master student in Biochemistry and Molecular biology with experience in Education and Research. I am passionate about scientific research and passing my knowledge to others to help them learn about the latest in science by teaching, writing and volunteering in scientific events.
You May Also Like
JAN 26, 2021
Clinical & Molecular DX
Prostate Cancer Screening: No More False Positives
JAN 26, 2021
Prostate Cancer Screening: No More False Positives
A new diagnostic test powered by artificial intelligence has been found to detect prostate cancer markers in urine sampl ...
MAR 22, 2021
Immunology
Gene Mutation Keeps Tumors "Cold"
MAR 22, 2021
Gene Mutation Keeps Tumors "Cold"
Immunologists have identified a mechanism through which an oncogene mutation shields pancreatic tumors from immune cells ...
MAR 12, 2021
Drug Discovery & Development
Drug Starves Melanoma Tumors
MAR 12, 2021
Drug Starves Melanoma Tumors
Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a drug candidate that blocks the uptake ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
Loading Comments...